Rare diseases
Investigational molecules
Locations
Boulevard Stephane Moreau, 85925 La Roche sur Yon, France
Centre Hospitalier Departemental Vendee in La Roche sur Yon, France specialises in clinical trials of conditions such as Plasma cell myeloma, Breast cancer, Non-small cell lung cancer, Colitis ulcerative, and other specialisations. This site conducts important research.
The center is at the forefront of cardiovascular medicine, focusing on innovative treatments for acute myocardial infarction. The AMUNDSEN-real trial exemplifies our commitment to advancing therapeutic strategies, particularly in the use of evolocumab to achieve significant LDL-C reduction.
Our research contributes to the development of personalized treatment plans that enhance patient outcomes in real-world settings.
Our center excels in respiratory medicine, with a particular emphasis on Chronic Pulmonary Aspergillosis. Through trials like CPAAARI, we explore the efficacy of combined antifungal therapies, enhancing treatment protocols for non-immunocompromised patients.
Our work aims to refine therapeutic approaches, improving both clinical and radiological outcomes for patients.
In the field of oncology, our center is pioneering research in multiple myeloma and other hematological malignancies. The IFM2020-05-BENEFIT study highlights our efforts in evaluating novel drug combinations to improve Minimal Residual Disease rates.
Our research is instrumental in developing targeted therapies that offer hope for better management of these complex conditions.
Our center is advancing the field of endocrinology through studies like the post-thyroidectomy hypocalcemia trial, which investigates the role of cholecalciferol supplementation in preventing complications after thyroid surgery.
We aim to enhance surgical outcomes and patient comfort through innovative preoperative strategies.
In rheumatology, our center is exploring advanced treatment options for rheumatoid arthritis. Trials like the combination of methotrexate with targeted therapies are pivotal in improving patient response and quality of life.
Our research is dedicated to finding more effective and personalized treatment regimens for chronic inflammatory conditions.
Our center is a leader in nephrology, focusing on innovative treatments for renal cell carcinoma and other kidney-related conditions. Studies comparing tivozanib combinations are crucial in enhancing therapeutic efficacy.
We strive to improve survival rates and quality of life for patients with advanced kidney diseases.
More sites in La Roche sur YonFrance
Clinical trials currently enrolling participants at this site.
Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
FranceFranceStudy on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure
FranceStudy on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis
FranceStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
FranceStudy of Beclometasone Dipropionate in Patients with Asthma to Evaluate Disease Characteristics and Control
FranceSafety and Tolerability of Alisertib Sodium and Paclitaxel in Patients with Small Cell Lung Cancer (Phase 2 Study)
FranceOne-Year Effectiveness Study of Guselkumab in Adults with Crohn’s Disease
FranceComparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
FranceEfficacy and Safety of Subcutaneous Belimumab in Adults with Connective Tissue Disease-Associated Interstitial Lung Disease
FranceA study testing how well AZD4144 works and how safe it is for adults with acute kidney injury caused by sepsis
FranceA study of coramitug compared to placebo for people with heart failure caused by transthyretin amyloid cardiomyopathy
FranceMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
